Heated vs. sprayed chemo: which works better for belly cancer?

NCT ID NCT07282834

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compares two methods of giving chemotherapy directly into the abdomen for people whose cancer has spread there (peritoneal carcinomatosis). One method, HIPEC, uses heated chemotherapy circulated during surgery. The other, PIPAC, delivers chemotherapy as a pressurized spray during a minimally invasive procedure. The trial will enroll 200 adults to see which approach is safer, better tolerated, and more effective.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Mitomycin C (chemotherapy)
What this could lead to
If successful, this trial could identify which direct-to-abdomen chemotherapy method is safer and more tolerable for patients with cancer spread in the belly.
What could go wrong
This is a mid-stage trial with 200 participants, so results may not apply to all patients. Both methods involve chemotherapy side effects and surgical risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allegheny Health Network West Penn Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.